| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |